Our three founding members – the University of Oxford, London School of Hygiene and Tropical Medicine, and Imperial College London – are world renowned leaders in vaccine research and development.

We have strong industry support from world leading vaccine experts Johnson and Johnson, MSD and Cytiva.

The VMIC facility has been established with funding from the UK Government through the Department for Business, Energy and Industrial Strategy.

VMIC has been established as a private company limited by guarantee without share capital.

 

Our founders
Support
Funding

Further Reading

History of VMIC

VMIC was founded in 2018 by world renowned academic and industry leaders in vaccines. In 2019 VMIC experts took a central role in tackling the COVID-19 pandemic.

Who we are

Our people are at the heart of everything we do. Our team has extensive experience and expertise in the biotechnology industry and knowledge economy.

The facility

Our advanced facility at the UK’s center for science and technology has state-of-the-art equipment, managed by experts in their field and is ready to help develop your vaccine.

Our purpose

VMIC is part of the UK’s national scientific infrastructure providing a strategic vaccine development and manufacturing capability for the benefit of UK and beyond.